Tislelizumab trials for Pancreatic cancer

All Tislelizumab trials · All Pancreatic cancer trials

Phase breakdown

Recruiting trials studying Tislelizumab for Pancreatic cancer

• A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic Cancer
  NCT07671339 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
  NCT05431270 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• tislelizUMaB in canceR Patients With molEcuLar residuaL Disease
  NCT06332274 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Tislelizumab for Pancreatic cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.